Concepedia

Brent Morse

BM

4

Publications

261

Citations

4

H-Index

1993

Active since

Affiliations

Bristol-Myers Squibb (Germany)(Current)

Bristol-Myers Squibb (United States)

Harvard University Press

Brent Morse is an author at Bristol-Myers Squibb (Germany) specializing in tumor biology, pathology, and cancer research.

Top concepts

Publications per year

1993–2012

4

Publications

4

Anti-tumor effect of CT-322 as an Adnectin inhibitor of vascular endothelial growth factor receptor-2

Roni Mamluk, Irvith M. Carvajal, Brent Morse et al. · mAbs · 2010 · 79 citations · Full text

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

Stuart L. Emanuel, Linda J. Engle, Ginger Chao et al. · mAbs · 2011 · 72 citations · Full text

Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing’s sarcoma A673-xenograft growth and normalize tumor vascular architecture

Maximilian Ackermann, Brent Morse, Vera Delventhal et al. · Angiogenesis · 2012 · 59 citations

, , +9

Constitutive expression of multidrug resistance in human colorectal tumours and cell lines

TK Weber, Brent Morse, R.J. Arceci et al. · British Journal of Cancer · 1993 · 51 citations · Full text

, , +9

Rows per page

1–4 of 4